PURPOSE OF REVIEW: In prior decades, liver cancer was viewed as a neoplasm that almost exclusively arose among high-risk populations in low- and middle-income countries. Incidence rates in some high-risk populations, however, have been declining, while rates in low-risk populations have been increasing, reflecting changes in underlying etiology. In this review, we highlight the evolving epidemiology of liver cancer, focusing on recent research and advances. RECENT FINDINGS: Efforts to reduce or eliminate the risk associated with major risk factors such as hepatitis B virus (HBV), hepatitis C virus (HCV) and aflatoxin B1 (AFB1) have met with some success. As opposed to these favorable trends, the joint epidemics of obesity and diabetes have begun to affect liver cancer rates around the world. SUMMARY: While there has been progress in combating the effects of some risk factors, the increasing prevalence of others poses a major threat to attempts to tackle the rising incidence of liver cancer globally.
PURPOSE OF REVIEW: In prior decades, liver cancer was viewed as a neoplasm that almost exclusively arose among high-risk populations in low- and middle-income countries. Incidence rates in some high-risk populations, however, have been declining, while rates in low-risk populations have been increasing, reflecting changes in underlying etiology. In this review, we highlight the evolving epidemiology of liver cancer, focusing on recent research and advances. RECENT FINDINGS: Efforts to reduce or eliminate the risk associated with major risk factors such as hepatitis B virus (HBV), hepatitis C virus (HCV) and aflatoxin B1 (AFB1) have met with some success. As opposed to these favorable trends, the joint epidemics of obesity and diabetes have begun to affect liver cancer rates around the world. SUMMARY: While there has been progress in combating the effects of some risk factors, the increasing prevalence of others poses a major threat to attempts to tackle the rising incidence of liver cancer globally.
Entities:
Keywords:
Non-alcohol fatty liver disease; aflatoxin; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; obesity
Authors: Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo Journal: Gastroenterology Date: 2005-07 Impact factor: 22.682
Authors: Yasuhito Tanaka; Kousuke Hanada; Masashi Mizokami; Anthony E T Yeo; J Wai-Kuo Shih; Takashi Gojobori; Harvey J Alter Journal: Proc Natl Acad Sci U S A Date: 2002-11-18 Impact factor: 11.205
Authors: T Stroffolini; A Mele; M E Tosti; G Gallo; E Balocchini; P Ragni; F Santonastasi; A Marzolini; M Ciccozzi; A Moiraghi Journal: J Hepatol Date: 2000-12 Impact factor: 25.083
Authors: C Frank; M K Mohamed; G T Strickland; D Lavanchy; R R Arthur; L S Magder; T El Khoby; Y Abdel-Wahab; E S Aly Ohn; W Anwar; I Sallam Journal: Lancet Date: 2000-03-11 Impact factor: 79.321
Authors: Jessica L Petrick; Andrea A Florio; Ariana Znaor; David Ruggieri; Mathieu Laversanne; Christian S Alvarez; Jacques Ferlay; Patricia C Valery; Freddie Bray; Katherine A McGlynn Journal: Int J Cancer Date: 2019-11-05 Impact factor: 7.316
Authors: Hung N Luu; Jaideep Behari; George Boon-Bee Goh; Renwei Wang; Aizhen Jin; Claire E Thomas; Jose C Clemente; Andrew O Odegaard; Woon-Puay Koh; Jian-Min Yuan Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-11-13 Impact factor: 4.090
Authors: Allisson B Justino; Rodrigo M Florentino; Andressa França; Antonio C M L Filho; Rodrigo R Franco; André L Saraiva; Matheus C Fonseca; Maria F Leite; Foued Salmen Espindola Journal: PLoS One Date: 2021-07-08 Impact factor: 3.240